Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Baxter
AstraZeneca
Colorcon
Johnson and Johnson

Last Updated: September 26, 2022

Benztropine mesylate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic sources for benztropine mesylate and what is the scope of freedom to operate?

Benztropine mesylate is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Luitpold, Navinta Llc, Akorn, Aspen Global Inc, Chartwell Rx, Epic Pharma Llc, Invagen Pharms, Lannett Co Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Upsher Smith Labs, Usl Pharma, Vintage, and Merck, and is included in twenty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for benztropine mesylate. Nineteen suppliers are listed for this compound.

Drug Prices for benztropine mesylate

See drug prices for benztropine mesylate

Drug Sales Revenue Trends for benztropine mesylate

See drug sales revenues for benztropine mesylate

Recent Clinical Trials for benztropine mesylate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
Boehringer IngelheimPhase 2

See all benztropine mesylate clinical trials

Pharmacology for benztropine mesylate
Medical Subject Heading (MeSH) Categories for benztropine mesylate

US Patents and Regulatory Information for benztropine mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn COGENTIN benztropine mesylate INJECTABLE;INJECTION 012015-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Vintage BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 040715-003 Aug 27, 2007 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Invagen Pharms BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 090294-003 Mar 29, 2010 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merck COGENTIN benztropine mesylate TABLET;ORAL 009193-004 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Epic Pharma Llc BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 072264-001 Feb 27, 1989 AA RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Medtronic
Express Scripts
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.